The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Authors:
Open Access
- 8 August 2022
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (7) , 3383-3393
Abstract
Purpose: Immune checkpoint inhibition is a therapeutic option in many cancer entities. In head and neck squamous cell carcinoma (HNSCC) targeting of the PD-1/PD-L1 (B7-H1) axis is approved in recurrent/metastatic disease and is being explored in the curative setting. Here, we evaluated two related members of the B7 family, B7-H3 & B7-H4, for their prognostic impact under standard treatment. Methods: A tissue microarray (TMA) of a single center HNSCC cohort was stained for B7-H3 and B7-H4. Staining intensity and the number of tumor cells stained were assessed, and the expression was scored according to an established algorithm. Staining scores were correlated with clinicopathological parameters and associated with patient survival. mRNA levels of both proteins were associated with patient outcome using the TCGA dataset. Results: mRNA levels of B7-H3 and B7-H4 were not significantly associated with patient survival. TMA analysis revealed interpretable protein staining in 408 samples. Strong staining was the most frequent category for B7-H3 and no staining for B7-H4. In patients with p16-negative oropharyngeal SCC (OPSCC) and in a pooled cohort consisting of p16-negative OPSCC, laryngeal, hypopharyngeal and oral cavity SCC, strong B7-H3 expression was associated with better overall survival. For the latter cohort, this was in part due to reduced lymph node involvement. B7-H3 expression in p16-positive OPSCC and B7-H4 expression were not associated with outcome. Conclusion: Despite a possible role in tumor immune escape, B7-H3 was associated with favorable prognosis in HPV-negative HNSCC in our cohort. The underlying mechanisms and a potential impact for B7-H3 targeting remain to be elucidated.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (02NUK032, 02NUK032, 02NUK032)
- Hamburger Krebsgesellschaft
- Universitätsklinikum Hamburg-Eppendorf (UKE)
This publication has 48 references indexed in Scilit:
- B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancerOncology Letters, 2016
- Tissue Microarrays2016
- Orchestrating high-throughput genomic analysis with BioconductorNature Methods, 2015
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancerInternational Journal of Cancer, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosisInternational Journal of Oncology, 2011
- Immunohistochemical Analysis of Tissue Microarrays2010
- Reshaping Data with thereshapePackageJournal of Statistical Software, 2007